Skip to main content

Research Repository

Advanced Search

Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)

Vasilev, Alex; Sofi, Roba; Smith, Stuart J.; Rahman, Ruman; Teschemacher, Anja G.; Kasparov, Sergey

Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM) Thumbnail


Authors

Alex Vasilev

Roba Sofi

Anja G. Teschemacher

Sergey Kasparov



Abstract

One of the most challenging problems in the treatment of glioblastoma (GBM) is the highly infiltrative nature of the disease. Infiltrating cells that are non-resectable are left behind after debulking surgeries and become a source of regrowth and recurrence. To prevent tumor recurrence and increase patient survival, it is necessary to cleanse the adjacent tissue from GBM infiltrates. This requires an innovative local approach. One such approach is that of photodynamic therapy (PDT) which uses specific light-sensitizing agents called photosensitizers. Here, we show that tetramethylrhodamine methyl ester (TMRM), which has been used to asses mitochondrial potential, can be used as a photosensitizer to target GBM cells. Primary patient-derived GBM cell lines were used, including those specifically isolated from the infiltrative edge. PDT with TMRM using low-intensity green light induced mitochondrial damage, an irreversible drop in mitochondrial membrane potential and led to GBM cell death. Moreover, delayed photoactivation after TMRM loading selectively killed GBM cells but not cultured rat astrocytes. The efficacy of TMRM-PDT in certain GBM cell lines may be potentiated by adenylate cyclase activator NKH477. Together, these findings identify TMRM as a prototypical mitochondrially targeted photosensitizer with beneficial features which may be suitable for preclinical and clinical translation.

Citation

Vasilev, A., Sofi, R., Smith, S. J., Rahman, R., Teschemacher, A. G., & Kasparov, S. (2021). Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM). Biomedicines, 9(10), Article 1453. https://doi.org/10.3390/biomedicines9101453

Journal Article Type Article
Acceptance Date Oct 9, 2021
Online Publication Date Oct 13, 2021
Publication Date Oct 13, 2021
Deposit Date Mar 4, 2022
Publicly Available Date Mar 8, 2022
Journal Biomedicines
Electronic ISSN 2227-9059
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 9
Issue 10
Article Number 1453
DOI https://doi.org/10.3390/biomedicines9101453
Keywords General Biochemistry, Genetics and Molecular Biology; Medicine (miscellaneous)
Public URL https://nottingham-repository.worktribe.com/output/7351302
Publisher URL https://www.mdpi.com/2227-9059/9/10/1453

Files





You might also like



Downloadable Citations